| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
| Company Name: |
Cckinase, Inc. |
| Tel: |
+1 (732)236-3202 |
| Email: |
sales@cckinase.com |
|
| | GLL398 Chemical Properties |
| Boiling point | 602.7±65.0 °C(Predicted) | | density | 1.24±0.1 g/cm3(Predicted) | | pka | 4.46±0.10(Predicted) |
| | GLL398 Usage And Synthesis |
| Uses | GLL398 is a potent, orally bioavailable selective estrogen receptor degrader (SERD) with an IC50 value of 1.14 nM. GLL398 shows a strong dose-dependent binding to ER with a mutation at Y537S (IC50=29.5 nM). GLL398 blocks tumor growth in xenograft models of breast cancer. | | References | [1] Guo S, et al. GLL398, an oral selective estrogen receptor degrader (SERD), blocks tumor growth in xenograft breast cancer models. Breast Cancer Res Treat. 2020;180(2):359-368. DOI:10.1007/s10549-020-05558-w |
| | GLL398 Preparation Products And Raw materials |
|